Category:Atypical antipsychotic: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
No edit summary
Zeki (talk | contribs)
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
[[Category: Drugs]][[Category: Brexpiprazole ]]
[[Category: Antipsychotic Drug]]


[[:Category: Atypical antipsychotic | '''Atypical antipsychotic ''']]
'''Atypical Antipsychotic'''(中文:[[:Category: 非典型抗精神病藥物 | 非典型抗精神病藥物]])
 
'''Drug class: [[:Category: Brexpiprazole | Brexpiprazole]]
 
'''Brexpiprazole (Rexulti)'''(中文:[[銳思定]])
 
==Common Strengths of Brexpiprazole Tablet==
Brexpiprazole tablets are available in the following strengths:
* 0.25 mg
 
* 0.5 mg
 
* 1 mg
 
* 2 mg
 
* 3 mg
 
* 4 mg
 
==Drug Trade Names of BrexpiprazoleBrexpiprazole Tablet==
Rexulti is the trade name for Brexpiprazole:
 
==Drug Usage==
Brexpiprazole is used for:
* Treatment of schizophrenia
* Adjunctive treatment of major depressive disorder (MDD)
* Treatment of agitation associated with dementia due to Alzheimer's disease
 
==Mechanism of Action==
Brexpiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors. It modulates dopaminergic and
 
serotonergic activity to improve symptoms of schizophrenia and depression
 
==Route of Administration==
Brexpiprazole is administered orally in the form of tablets or liquid solution.
 
==Dosages==
* Schizophrenia (Adults): Initial dose of 1 mg once daily, titrated to 2 mg on Day 5 to 7, and up to 4 mg by Day 8. Target dose: 2 to 4 mg daily. Maximum dose: 4 mg/day.
 
* Depression (Adults): Initial dose of 0.5 mg or 1 mg once daily, titrated to 2 mg daily. Maximum dose: 3 mg/day.
* Pediatric Schizophrenia (13-17 years): Initial dose of 0.5 mg once daily, titrated to 1 mg on Day 5 to 7, and up to 2 mg by Day 8. Maximum dose: 4 mg/day.
 
For patients with moderate to severe renal impairment, the dosage of brexpiprazole should be reduced to a maximum of 3 mg per day for schizophrenia and 2 mg per day for MDD.
 
No adjustment is needed for mild renal impairment.
 
==Side Effects==
{| class="wikitable"
!style="text-align: left"| Frequency
!Adverse reactions
|-
| rowspan="12" | '''Common
| Weight gain
|-
| Akathisia (feeling of restlessness, constant urge to move)
|-
| Headache
|-
| Drowsiness/sleepiness
|-
| Dizziness
|-
| Nausea
|-
|  Constipation
|-
| Indigestion/heartburn
|-
| Increased appetite
|-
| Fatigue/tiredness
|-
| Tremor
|-
| Stuffy or runny nose
|-
| rowspan="13" | '''Uncommon
| Neuroleptic malignant syndrome (high fever, muscle stiffness, confusion)
|-
| Tardive dyskinesia (uncontrolled muscle movements)
|-
| High blood sugar/diabetes
|-
| Orthostatic hypotension (dizziness when standing up)
|-
| Seizures
|-
| Low white blood cell count
|-
| Difficulty swallowing
|-
| Suicidal thoughts or behaviors (especially in young adults)
|-
| Compulsive behaviors (gambling, sexual urges, binge eating)
|-
| Cognitive impairment
|-
| Impaired body temperature regulation
|-
| Stroke in elderly patients with dementia-related psychosis
|-
| Allergic reactions (rash, itching, difficulty breathing)
|}
 
==Pharmacokinetics==
*Absorption
**Peak plasma concentration within 4 hours.
*Metabolism
**Primarily metabolized by CYP3A4 and CYP2D6.
*Excretion
**25% in urine and 46% in feces. Terminal elimination half-life is approximately 91 hours.
 
Initial effects: Some patients may begin to see improvements within 1 to 2 weeks of starting treatment.
 
Full Therapeutic Effects: The best results are typically observed after 4 to 6 weeks for schizophrenia and major depressive disorder (MDD) For agitation associated with
 
dementia due to Alzheimer's disease, significant results may be seen in about 12 weeks.
 
==Drug Precautions==
'''Increased risk in elderly patients
 
*Should not be used to treat dementia-related psychosis in older adults due to increased risk of stroke and death
*May cause drowsiness, dizziness, and difficulty swallowing in elderly patients, increasing the risk of falls and choking
 
'''Suicidal thoughts in young people
 
*May increase the risk of suicidal thoughts in young people under 24 years old, especially in the first few months of treatment or with dose changes
*Close monitoring is required for children/teens taking aripiprazole
 
'''Use cautiously in patients with a history of seizures or with conditions that lower the seizure threshold.
 
'''Dysphagia
 
*Esophageal dysmotility and aspiration associated with antipsychotic drug use
*Use cautiously in patients at risk for aspiration pneumonia
 
'''Monitoring Requirements
*Regular monitoring of blood sugar levels, weight, and signs of extrapyramidal symptoms
*Perform complete blood count (CBC) in patients with pre-existing low white blood cell count (WBC) or history of drug-induced leukopenia/neutropenia
*Monitor heart rate and blood pressure and warn patients with known cardiovascular or cerebrovascular disease, and risk of dehydration or syncope
 
'''Drug Interactions
 
*Avoid strong CYP3A4 inducers and inhibitors
 
==FAQ==
'''How Should I Take the Tablet?
*  Take brexpiprazole once daily with or without food, at the same time each day.
 
''What should I avoid while taking brexpiprazole?
*Avoid alcohol, and activities requiring alertness until you know how the medication affects you. Avoid overheating and dehydration
 
'''What Happens if I Miss a Dose?
*Take the missed dose as soon as you remember unless it is almost time for your next dose. Do not double doses.

Latest revision as of 22:02, 24 July 2024


Atypical Antipsychotic(中文: 非典型抗精神病藥物

Pages in category "Atypical antipsychotic"

The following 8 pages are in this category, out of 8 total.